相关实验视频

Updated: Jun 27, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

TIM3和CTLA4免疫检查点多形态与沙特阿拉伯的急性髓性白血病有关

Mashael Alqahtani1, Ali Aljuaimlani1, Jameel Al-Tamimi1

  • 1Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Hematology (Amsterdam, Netherlands)
|March 27, 2024
PubMed
概括

这项研究检查了沙特急性髓性白血病 (AML) 患者的免疫检查点基因变异 (CTLA-4和TIM-3). TIM-3多态性增加了AML风险,而CTLA-4变异提供了保护.

关键词:
在 CTLA-4 中.血液学的恶性瘤.免疫检查点分子的分子.沙特阿拉伯 沙特阿拉伯 沙特阿拉伯在TIM-3中,TIM-3是TIM-3.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.单个核酸的多态性.

更多相关视频

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.6K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...